Literature DB >> 7560115

Orthognathic surgery in osteogenesis imperfecta: a case report with management considerations.

I W Ormiston1, H Tideman.   

Abstract

Osteogenesis imperfecta is a disease of connective tissues with additional metabolic defects. It is associated with recognisable facial disproportion and sometimes warrants surgical intervention for aesthetic, functional and psychological reasons. A severe case of osteogenesis imperfecta type 3 is presented to illustrate the feasibility of bimaxillary surgery using a mandibular body step osteotomy and maxillary down grafting at the Le Fort I level. The medical, anaesthetic, surgical and specific maxillofacial implications of surgery in these patients are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7560115     DOI: 10.1016/s1010-5182(05)80219-7

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  4 in total

1.  Osteogenesis imperfecta and combined orthodontics and orthognathic surgery: a case report on two siblings.

Authors:  Dong-Young Kim; Unbong Baik; Ju-Hong Jeon
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-02-26

2.  Dentinogenesis Imperfecta and Caries in Osteogenesis Imperfecta among Vietnamese Children.

Authors:  Huong Thi Thu Nguyen; Dung Chi Vu; Duc Minh Nguyen; Quang Dinh Dang; Van Khanh Tran; Hung Le; Son Minh Tong
Journal:  Dent J (Basel)       Date:  2021-04-27

3.  Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - A retrospective cohort study.

Authors:  Kristofer Andersson; Göran Dahllöf; Katarina Lindahl; Andreas Kindmark; Giedre Grigelioniene; Eva Åström; Barbro Malmgren
Journal:  PLoS One       Date:  2017-05-12       Impact factor: 3.240

4.  Closed rhinoseptoplasty in patient with Van der Hoeve-De Klein Syndrome.

Authors:  Raíssa Ferreira Gonçalves; Rafael Alves Cordeiro; Charisse Assuane de Araujo Patrício; Camila Atallah Pontes da Silva; Priscila Bogar Rapoport
Journal:  Braz J Otorhinolaryngol       Date:  2014 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.